Boston Medical Group Review

Boston Medical Group: a low headline price built around a fixed program

Boston Medical Group is an established telehealth practice — run out of a corporate headquarters in Huntington Beach, California, not Boston, despite the name — that sells semaglutide as a structured three-month weight-loss program rather than an open-ended monthly subscription. The reason most people land here is the number: at $66 a month it advertises one of the lowest entry prices in the GLP-1 space, well under the category median of $170. If you are shopping purely on sticker price and want compounded medication without a lot of frills, it earns a look. Just go in clear-eyed about what that low figure does and doesn't include.

How the pricing actually works

This is the part that trips people up, so read it twice. The $66 headline covers the medication, but the consultation is not bundled in — a separate telemedicine platform fee is billed on top of the drug cost. The initial phone consult is free, which is a genuine plus, but the ongoing platform charge is the line item that quietly raises your real monthly spend above the advertised rate. There is no first-month teaser price to lure you in; the rate is the rate. Because the program is sold in a fixed multi-month block rather than month to month, you are effectively committing to a course up front rather than paying as you go, so price the whole program, not just the first invoice.

One honest caveat: pricing in this corner of the market moves fast, and Boston Medical Group's published rate has drifted between checks. Before you hand over a card, confirm the current monthly figure, the platform fee, and the total program cost directly on the provider's own checkout — don't trust a number you saw quoted elsewhere, including here.

The medications and how they're dispensed

Boston Medical Group prescribes compounded semaglutide and tirzepatide — the same two active ingredients found in the brand-name injectables, made by a compounding pharmacy rather than the original manufacturer. There is no brand-name Wegovy, Ozempic, or Zepbound option and no oral tablet; this is injectable compounded medication only. Compounding is what makes the low price possible, but it also means the product isn't FDA-approved the way the brand pens are, so it sits in a more lightly regulated lane. To its credit, the record shows no FDA warning letters or enforcement actions on file against this provider.

Where it actually operates

This is a regional service, not a nationwide one. Boston Medical Group treats patients in seven states — California, Texas, Washington, Michigan, New York, Colorado, and Florida. If you live outside those, you simply can't enroll, so check the list before you get attached to the price. Earlier directory data wrongly listed all fifty states; the seven-state footprint is the verified, accurate picture.

What sets it apart — and what's missing

The real differentiator is straightforward: aggressive pricing on compounded GLP-1s from a practice that has been operating in men's and general health for years, paired with a free initial phone consult. For a budget-conscious shopper in one of its seven states, that combination is the whole pitch.

What's missing is detail. Compared with providers that spell out their compounding pharmacy, accreditation, dose-titration schedule, included clinician messaging, and refund terms, Boston Medical Group publishes relatively little about the mechanics of the program. The record lists no named compounding-pharmacy partner and no accreditation quote, which means you're trusting the brand rather than a documented supply chain. That isn't a red flag on its own, but it is a gap — and it's the main reason this provider doesn't score higher in our scoring methodology.

Who should choose it

• Budget-first shoppers who want the lowest realistic entry price on compounded semaglutide or tirzepatide
• Residents of CA, TX, WA, MI, NY, CO, or FL — the only states served
• People comfortable with compounded (non-brand) medication and a fixed multi-month program rather than month-to-month flexibility
• Anyone who values a free initial phone consultation before committing

Who should skip it

• Anyone who needs brand-name Wegovy, Ozempic, Mounjaro, or Zepbound — none are offered here
• Patients outside the seven covered states
• Shoppers who want full transparency on the pharmacy, accreditation, and exact program terms before paying
• People who want true pay-as-you-go billing or an all-in price with no separate platform fee

Trust and medical oversight

Boston Medical Group is a long-running medical practice with a clean regulatory record — no FDA warnings appear in our verification. Care is delivered by prescribing clinicians, and the free initial phone consult is a reasonable on-ramp. The honest limitation is documentation: with no published compounding partner or accreditation detail, our confidence rests on the practice's track record rather than a fully transparent supply chain. That's enough for a budget pick, but not enough to call it a best-in-class oversight model.

Bottom line

Boston Medical Group is a price play. If you live in one of its seven states, want compounded semaglutide or tirzepatide, and are willing to commit to a fixed multi-month program, the $66 starting rate is hard to beat — just remember to add the separate platform fee to get your true cost, and verify the live pricing before you pay. If you need brand-name medication, nationwide access, month-to-month flexibility, or detailed transparency about the pharmacy behind your prescription, you'll be better served elsewhere.

For a side-by-side, Telos Rx ($49/month) and bmiMD ($99/month) are the most comparable options to weigh against Boston Medical Group.